A new tech tool is helping United Way of Greater Houston to connect nonprofits to those who need their services. Photo via Getty Images

A first-of-its-kind tech tool will help thousands of people in the Houston area get on their feet financially.

United Way of Greater Houston says the new Integrated Client Journey Technology Tool will eventually connect more than 100 nonprofits serving financially struggling households in the United Way’s four-county service area (Fort Bend, Harris, Montgomery, and Waller). Houston’s nonprofit Patient Care Intervention Center developed the cloud-based tool.

The tool is expected to launch in the fall of 2022.

A team of navigators will use the tool as they steer families and individuals toward financial stability. The tool will help navigators and clients identify and access services based on clients’ needs and goals. Among these services are workforce development, financial coaching, early childhood and youth development, and physical and behavioral healthcare.

According to United Way, 14 percent of Houston-area households live on incomes below the federal poverty line, and another 33 percent of working households don’t earn enough money to afford basic necessities.

“At United Way, we’re focused on connecting people with possibility,” Amanda McMillian, president and CEO of United Way of Greater Houston, says in a news release.

“When you’re working multiple jobs, caring for a family and living paycheck to paycheck, navigating the network of social service resources can be a daunting task,” she adds. “The goal of our technology tool is to dramatically improve access to these resources by making it easier for you to connect with the services you need, assisted by a skilled navigator who knows your goals.”

McMillian says United Way’s overarching vision for the tool is to connect all nonprofit service providers in the area in an effort to improve access for clients and enhance coordination among providers.

On a pro bono basis, Boston Consulting Group, which has an office in Houston, came up with the proof-of-concept version of the United Way tool.

Kettering, Ohio-based Reynolds and Reynolds, a developer of software for car dealerships, made the initial donation to help underwrite the tool. Reynolds and Reynolds has offices in Houston and College Station.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.